Progressive Care has broken strongly out of the startup
Progressive Care has broken strongly out of the startup stage as a unique health services business and is strategically positioning its wholly owned subsidiary PharmCo as an upcoming national brand - expanding the market and customer base in south Florida, and this year looking to expand upward into the eastern coastal states through acquisition.
The company is now profitable and has cleared all debt from the balance sheet in 2015. Debt was accumulated from initial founding in 2007 through 2014, while building a strong core business and consistently increasing year over year revenue, to the current level of ~$15M (annualized).
The company is currently at $15M net sales with a market cap of only $6.65M. Part of this is due to a previously depressed pps while the stock was being diluted to pay down the debt, in combination with the prior "OTC Pink Limited Info" status (yield sign on OTC Markets). A price correction is ongoing since the "zero debt" milestone in December, and the yield sign was removed just last week on Jan 8 as RXMD was upgraded to "Current Information."
The COO was just promoted to CEO after a solid performance as COO, and will be agressively pursuing the vision of PharmCo as a national brand through 2016 and beyond.
As a profitable business in a high-demand, high-growth, high-margin market with zero debt and a flawless record of QoQ and YoY revenue growth over the past 3 years, Progressive Care is well-positioned to replicate the PharmCo "franchise" model to achieve this national PharmCo brand vision.
Progressive Care Inc. (RXMD) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
Top 5 Most Recently Viewed Articles
Cofactor Genomics Appoints Chris Parker as New CEO Cofactor Genomics, Inc., a commercial-stage company dedicated to bridging the precision medicine gap through RNA decoding, has announced a significant leadership transition. Chris Parker has been appointed as the new CEO and Board Member, succeeding Jarret Glasscock, who will continue his contributions in the roles of...
Continue Reading
Minto Apartment REIT's Cash Distribution Announcement Minto Apartment Real Estate Investment Trust (MI) has recently made an important announcement regarding its cash distribution. The REIT has declared a monthly cash distribution of $0.04333 per unit for the month of July 2025. This translates to an annualized rate of $0.52 per unit. The payment is set to be distributed...
Continue Reading
Expanding Exploration: National Geographic–Lindblad's New Chapter in Alaska National Geographic–Lindblad Expeditions is celebrating a significant milestone in its quest to enhance adventure travel in Alaska, with plans to expand its offerings starting in 2027. The company is known for its pioneering spirit and leadership in expedition travel, and this expansion is a...
Continue Reading
Brian Krause Appointed as Chief Development Officer at Panera Bread Panera Bread, a leader in the fast casual dining sector, has recently announced the appointment of Brian Krause as its new Chief Development Officer. With a wealth of experience in franchise development and strategic growth, Krause aims to propel the company's expansion plans. Krause's Experience and...
Continue Reading
Blockmate Ventures Expands Its Horizons with New Investment Blockmate Ventures Inc. (TSX.V: MATE), a company recognized for its innovative approach in the tech world, has recently announced a significant investment commitment of CAD $1,400,000. This strategic funding comes from a group of investors, featuring notable industry figure Antanas Guoga, popularly known as Tony...
Continue Reading